Invariant NKT (iNKT) cells are an innate type of T cells, which respond rapidly on activation. iNKT cells acquire these innatelike abilities during development; however, the signals driving development and functional maturation remain only partially understood. Because interleukin-15 (IL-15) is crucial for iNKT development and is delivered by transpresentation, we set out to identify the cell types providing IL-15 to developing iNKT cells and determine their role at the various states of development and maturation. We report here that transpresentation of IL-15 by parenchymal cells was crucial for generating normal number of iNKTs in the thymus, whereas both hematopoietic and parenchymal cells regulated iNKT cell numbers in the periphery, particularly in the liver. Specifically, dendritic cells contributed to peripheral iNKT cell numbers by up-regulating Bcl-2 expression and promoting extrathymic iNKT cell expansion and their homeostatic proliferation.
IntroductionCD1-dependent invariant natural killer T (iNKT) cells are a unique population of T cells as these cells are functionally active immediately on stimulation and thus behave in an innate-like fashion. [1][2][3] iNKT cells are defined by the expression of an invariant T-cell receptor-␣ (TCR-␣) chain (V␣14-J␣18 in mice, and V␣24-J␣18 in humans) along with multiple NK cell-surface markers. [4][5][6][7][8] Interestingly, iNKT cells display immunoregulatory activity that includes the ability to either enhance or suppress immune responses. [9][10][11][12][13] These unique abilities of iNKT cells are acquired during development.Similar to conventional T cells, iNKT cell development occurs in the thymus; however, the developmental process of iNKT cells does not follow the conventional pathway. 14-16 Developing iNKT cells go through multiple transitional stages that can be followed by staining with CD1d tetramers along with other cell-surface markers (eg, CD4, CD44, and NK1.1). 17 The earliest detectable stage of iNKT cell development occurs after positive selection by CD1d ϩ thymocytes and is marked by expression of CD4 ϩ CD44 Low NK1.1 Ϫ . 18-20 Double-negative (DN, CD4 Ϫ CD8 Ϫ ) iNKT subsets also exist, but the stage where CD4 is down-regulated giving rise to the DN population is currently an ambiguous developmental event. In addition, the significance of the DN population is unclear. Despite being immature, both DN and CD4 ϩ CD44 Low NK1.1 Ϫ iNKT cells are capable of producing interleukin-4 (IL-4). 15,21 These immature iNKT cells expand and differentiate into CD44 High cells, which are capable of producing both IL-4 and interferon-␥ (IFN-␥) and exiting the thymus to seed the periphery. 15,21 The final stage of development or maturation is demarcated by NK1.1 expression, cell expansion, and an enhanced expression of IFN-␥ with minimal IL-4 expression. 15,21 Again, atypical of normal conventional T-cell development, this final stage of maturation of iNKT cells can occur either in the thymus or the periphery.Although maturation of iNKT cells is usually defined b...